40 results on '"Etra, Aaron"'
Search Results
2. A validated risk stratification that incorporates MAGIC biomarkers predicts long term outcomes in pediatric patients with acute GVHD
3. Flares of Acute Graft-Versus-Host Disease (GVHD): A Mount Sinai Acute GVHD International Consortium (MAGIC) Analysis
4. Ibrutinib for Therapy of Steroid-Refractory Chronic Graft Vs. Host Disease: A Multicenter Real-World Analysis
5. The Mount Sinai Acute Gvhd International Consortium (MAGIC) Model: An Integrated Clinical and Biomarker Grading System for Acute Graft-Versus-Host Disease (GVHD)
6. The MAGIC Algorithm Probability Predicts Treatment Response and Long-Term Outcomes to Second-Line Therapy for Acute Gvhd
7. A Day 14 Endpoint for Acute GVHD Clinical Trials
8. Acute Graft‐versus‐Host Disease
9. The utility of biomarkers in acute GVHD prognostication
10. Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease
11. Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD
12. Effective treatment of low-risk acute GVHD with itacitinib monotherapy
13. De Novo Late Acute Gvhd: Incidence, Outcomes, and Impact of Biomarkers Compared to Classic Acute Gvhd
14. REPOGRAMING OF THE INTESTINAL IMMUNE CELL COMPARTMENT DEFINES THE RESPONSE TO AUTOLOGOUS STEM CELL TRANSPLANTATION IN CROHNS DISEASE
15. Effective Treatment of Low Risk Acute Gvhd with Itacitinib Monotherapy
16. SARS-CoV-2 infection associated with aplastic anemia and pure red cell aplasia
17. Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification
18. Mo1537: COMBINATION AUTOLOGOUS STEM CELL TRANSPLANTATION AND VEDOLIZUMAB FOR REFRACTORY CROHN’S DISEASE
19. Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease
20. Pathogenic Germline Variants in Multiple Myeloma
21. Prognostic Value of Elafin in Acute Graft-Versus-Host Disease
22. P-063: Pathogenic germline variants in hereditary cancer genes in patients with Multiple Myeloma
23. Abstract 868: Heritable cancer mutations in multiple myeloma
24. A Case of Rare Autoimmune Pancytopenia Due to Graves’ Disease
25. Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin
26. Current and Emerging Targeted Therapies for Acute Graft-Versus-Host Disease
27. The MAGIC Algorithm Probability (MAP) Is a Validated Response Biomarker of Treatment for Acute Graft-Versus-Host Disease
28. Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant
29. The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease
30. The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host Disease
31. Thyroid Cancer
32. Comparison of Gvhd Biomarker Algorithms for Predicting Lethal Gvhd and Non-Relapse Mortality
33. Serial Biomarker Monitoring Early after HCT Identifies Different Risks for Relapse and Graft-Vs-Host Disease
34. Evaluating the safety of emicizumab in patients with hemophilia A
35. MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD
36. Rethinking clinical trial design: maximizing the results from each clinical trial participant
37. Abstract 3849: Analysis of the mutation rate in T lymphoblastic leukemia cell lines
38. Tu2029 Recent Causes of Hepatocellular Carcinoma in a U.S. Urban Medical Center
39. Death of Woman with Peripartum Influenza B Virus Infection and Necrotizing Pneumonia
40. Insights from the Front Lines of Nutraceutical Research: The Third International Conference on Mechanisms of Action of Nutraceuticals (ICMAN 3)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.